VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration DOI Creative Commons

Shirel Argueti-Ostrovsky,

Shir Barel,

Joy Kahn

и другие.

Biomolecules, Год журнала: 2024, Номер 15(1), С. 33 - 33

Опубликована: Дек. 30, 2024

Voltage-Dependent Anion Channel 1 (VDAC1) is a mitochondrial outer membrane protein that plays crucial role in regulating cellular energy metabolism and apoptosis by mediating the exchange of ions metabolites between mitochondria cytosol. Mitochondrial dysfunction oxidative stress are central features neurodegenerative diseases. The pivotal functions VDAC1 controlling permeability, calcium balance, facilitating programmed cell death pathways, position it as key determinant delicate balance neuronal viability degeneration. Accordingly, increasing evidence suggests implicated pathophysiology diseases, including Alzheimer’s disease (AD), Parkinson’s (PD), amyotrophic lateral sclerosis (ALS), others. This review summarizes current findings on contribution to neurodegeneration, focusing its interactions with disease-specific proteins, such amyloid-β, α-synuclein, mutant SOD1. By unraveling complex involvement processes, this highlights potential avenues for future research drug development aimed at alleviating mitochondrial-related neurodegeneration.

Язык: Английский

Therapeutic approaches targeting aging and cellular senescence in Huntington's disease DOI Creative Commons
Asif Ahmad Bhat, Ehssan Moglad, Muhammad Afzal

и другие.

CNS Neuroscience & Therapeutics, Год журнала: 2024, Номер 30(10)

Опубликована: Окт. 1, 2024

Huntington's disease (HD) is a devastating neurodegenerative that manifested by gradual loss of physical, cognitive, and mental abilities. As the advances, age has major impact on pathogenic signature mutant huntingtin (mHTT) protein aggregation. This review aims to explore intricate relationship between aging, mHTT toxicity, cellular senescence in HD. Scientific data interplay mHTT, HD were collected from several academic databases, including PubMed, Google Scholar, Google, ScienceDirect. The search terms employed "AGING," "HUNTINGTON'S DISEASE," "MUTANT HUNTINGTIN," "CELLULAR SENESCENCE." Additionally, gather information molecular mechanisms potential therapeutic targets, was extended include relevant such as "DNA DAMAGE," "OXIDATIVE STRESS," "AUTOPHAGY." According research, aging leads worsening pathophysiology through some processes. result accumulation, promoted, which causes DNA damage, oxidative stress, decreased autophagy, increased inflammatory responses. Pro-inflammatory cytokines other substances are released senescent cells, may worsen neuronal damage course disease. It been shown treatments directed at these pathways reduce symptoms enhance longevity experimental animals, pointing new possibility treating condition. Through their amplification harmful effects play crucial roles development Comprehending interplays creates novel opportunities for measures targeted alleviating enhancing patients' quality life.

Язык: Английский

Процитировано

6

Role of cytokines and reactive oxygen species in brain aging DOI Creative Commons
Sheba M.J. MohanKumar,

Abarna Murugan,

Arunkumar Palaniyappan

и другие.

Mechanisms of Ageing and Development, Год журнала: 2023, Номер 214, С. 111855 - 111855

Опубликована: Авг. 3, 2023

Язык: Английский

Процитировано

16

Mitochondrial targeted antioxidants as potential therapy for huntington’s disease DOI
Shubham Upadhayay, Puneet Kumar

Pharmacological Reports, Год журнала: 2024, Номер 76(4), С. 693 - 713

Опубликована: Июль 9, 2024

Язык: Английский

Процитировано

5

Morin suppresses mTORc1/IRE-1α/JNK and IP3R-VDAC-1 pathways: Crucial mechanisms in apoptosis and mitophagy inhibition in experimental Huntington's disease, supported by in silico molecular docking simulations DOI

Mohamed A. El-Emam,

Eman Sheta, Hanan S. El‐Abhar

и другие.

Life Sciences, Год журнала: 2023, Номер 338, С. 122362 - 122362

Опубликована: Дек. 21, 2023

Язык: Английский

Процитировано

11

Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives DOI Creative Commons
Ching‐Pang Chang,

Ching-Wen Wu,

Yijuang Chern

и другие.

Neurobiology of Disease, Год журнала: 2024, Номер unknown, С. 106672 - 106672

Опубликована: Сен. 1, 2024

Язык: Английский

Процитировано

4

Combined effects of a pharmaceutical pollutant, gemfibrozil, and abiotic stressors (warming and air exposure) on cellular stress responses of the blue mussels Mytilus edulis DOI Creative Commons
Halina Falfushynska, Eugene P. Sokolov, Inna M. Sokolova

и другие.

Aquatic Toxicology, Год журнала: 2025, Номер 279, С. 107233 - 107233

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Intranuclear TCA and mitochondrial overload: the nascent sprout of tumors metabolism DOI

Weixi Yuan,

Guozhong Lu, Yin Zhao

и другие.

Cancer Letters, Год журнала: 2025, Номер unknown, С. 217527 - 217527

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Hypertrophic Cardiomyopathy Through the Lens of Mitochondria DOI Creative Commons
Tatiana V. Kirichenko, Ivan V. Zhivodernikov, Maria A. Kozlova

и другие.

Biomedicines, Год журнала: 2025, Номер 13(3), С. 591 - 591

Опубликована: Фев. 28, 2025

The mechanisms of pathogenesis hypertrophic cardiomyopathy are associated with mutations in the sarcomere genes cardiomyocytes and metabolic disorders cell, including mitochondrial dysfunction. Mitochondria characterized by presence their own DNA enzyme complexes involved oxidative reactions, which cause damage to protein structures membranes reactive oxygen species. Mitochondrial dysfunctions can also be encoding proteins lead a violation protective functions such as mitophagy, fusion, fission. Mutations myofibril negatively affect mitochondria through increased stress due an need for ATP. dysfunction is impaired ATP synthesis cardiac contractility, leading clinical manifestations cardiomyopathy. current review was designed characterize role based on published data; search publications analysis articles keywords “hypertrophic cardiomyopathy, mitochondria, dysfunction” PubMed Scopus databases up January 2025.

Язык: Английский

Процитировано

0

Bezafibrate-driven mitochondrial targeting enhances antitumor immunity and prevents lung cancer via CD8+ T cell infiltration and MDSC reduction DOI Creative Commons

Jing Pan,

Jiaheng Li, Qi Zhang

и другие.

Frontiers in Immunology, Год журнала: 2025, Номер 16

Опубликована: Апрель 15, 2025

Bezafibrate (BEZ) is a drug used to treat hypertriglyceridemia and its long-term use has been associated with reduced risk of cancer in patients coronary artery disease. Recent studies uncovered that BEZ potent modulator mitochondrial biogenesis through activation PGC-1α/PPAR complexes, resulting modulation lipid metabolism fatty acid oxidation. Mitochondria impact virtually all processes linked oncogenesis, disruption normal bioenergetics oxidative phosphorylation (OXPHOS) occurs early during oncogenesis change the energy cells as well various tumor microenvironment (TME). Therefore, we synthesized analog (Mito-BEZ) preferentially localizes mitochondria, thereby enabling lower doses Mito-BEZ than achieve greater efficacy. Our demonstrate significantly more at inhibiting LUAD cell growth vitro lung tumorigenesis preclinical mouse models. was also >200-fold both complex I III cells. Furthermore, suppresses while markedly upregulating function effector CD8+ T cells, immune response TME. results show Mito-BEZ, favorable toxicity profile, exhibited striking inhibitory effect on progression metastasis by targeting fundamental difference metabolic plasticity between

Язык: Английский

Процитировано

0

Protective effects of the PPAR agonist bezafibrate against disruption of redox and energy homeostasis, neuronal death, astroglial reactivity, and neuroinflammation induced in vivo by D-2-hydroxyglutaric acid in rat brain DOI
Rafael Teixeira Ribeiro, Manuela Bianchin Marcuzzo, Andrey Vinícios Soares Carvalho

и другие.

European Journal of Pharmacology, Год журнала: 2024, Номер 987, С. 177186 - 177186

Опубликована: Дек. 6, 2024

Язык: Английский

Процитировано

2